You are here: Industry Insights > Brexit

News List

Brexit impact on UK pharma industry a moveable feast, industry experts tell CPhI Discover cphi-online
May 21, 2021
The UK’s withdrawal from the European Union has meant the pharmaceutical industry has had to adapt to some monumental changes in terms of research, regulatory affairs, and trade.
Post-Brexit point-based immigration system will affect the UK’s healthcare system: Poll pharmaceutical-technology
April 16, 2021
The UK government commenced taking applications for the new Skilled Worker Visa from January 2021, based on the new post-Brexit points-based visa and immigration system.
Cross-EU drug supply chain to be most affected post Brexit: Poll pharmaceutical-technology
January 22, 2021
The UK’s decision to opt out of the European Union (EU) has set numerous industries up for disruptions especially after the official exit in January 2020.
Pharma urged to review anti-counterfeiting strategies ahead of no-deal Brexit europeanpharmaceuticalreview
October 29, 2020
According to various associations, the UK could experience a high influx of counterfeit medicines if it leaves the EU without a deal.
ABPI chief exec says no-deal Brexit is ‘not in the interest of patients’ pharmatimes
October 21, 2020
Following prime minister Boris Johnson’s announcement last week that he was preparing for a no-deal with the EU, the Association for the British Pharmaceutical Industry (ABPI) has warned against such an outcome.
COVID-19 to influence the outcome of Brexit: Poll pharmaceutical-technology
October 15, 2020
The Brexit transition deadline of 31 December 2020 is fast approaching, but a trade deal between the UK and European Union (EU) is yet to be finalised.
Medicine suppliers in UK urged to stockpile in preparation for end of Brexit transition period europeanpharmaceuticalreview
August 05, 2020
The UK government has written an open letter to medicine suppliers, outlining how supply can be maintained after the end of the Brexit transition period.
Evolving World of Pharma: Defining the precise impact of Brexit? Sarah Harding
January 31, 2020
Shortly ahead of the delayed exit deadline of January 31st, it was already clear that – in the UK in particular – Brexit was going to have an impact this year.
Pharma bodies confirm signing NDAs for no-deal Brexit plans europeanpharmaceuticalreview
August 16, 2019
The DHSC has confirmed that several pharmaceutical industry bodies have agreed to NDAs regarding plans for a no-deal Brexit.
Is the pharma sector ready for a ‘no-deal’ Brexit? europeanpharmaceuticalreview
May 17, 2019
Is the pharma sector ready for a ‘no-deal’ Brexit?

Previous page 1 2 3 4 5 6 7 8 Next page